These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11932977)

  • 1. Pathophysiology of weakness in a patient with congenital end-plate acetylcholinesterase deficiency.
    Kohara N; Lin TS; Fukudome T; Kimura J; Sakamoto T; Kaji R; Shibasaki H
    Muscle Nerve; 2002 Apr; 25(4):585-92. PubMed ID: 11932977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological study in synaptic congenital myasthenic syndrome: end-plate acetylcholinesterase deficiency.
    Lorenzoni PJ; Scola RH; Gervini BL; Kay CS; Werneck LC
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):502-4. PubMed ID: 19623452
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism hypotheses for the electrophysiological manifestations of two cases of endplate acetylcholinesterase deficiency related congenital myasthenic syndrome.
    Ding Q; Shen D; Dai Y; Hu Y; Guan Y; Liu M; Cui L
    J Clin Neurosci; 2018 Feb; 48():229-232. PubMed ID: 29150079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
    Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
    Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG; Lambert EH; Gomez MR
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.
    Ishigaki K; Nicolle D; Krejci E; Leroy JP; Koenig J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2003 Mar; 13(3):236-44. PubMed ID: 12609505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of acetylcholinesterase deficiency for neuromuscular functioning.
    Mouisel E; Blondet B; Escourrou P; Chatonnet A; Molgó J; Ferry A
    Neurosci Res; 2006 Aug; 55(4):389-96. PubMed ID: 16766072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2.
    Maselli RA; Wan J; Dunne V; Graves M; Baloh RW; Wollmann RL; Jen J
    Neurology; 2003 Dec; 61(12):1743-8. PubMed ID: 14694040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
    Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
    Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel congenital myasthenic syndromes associated with defects in quantal release.
    Milone M; Fukuda T; Shen XM; Tsujino A; Brengman J; Engel AG
    Neurology; 2006 Apr; 66(8):1223-9. PubMed ID: 16525123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital endplate acetylcholinesterase deficiency.
    Hutchinson DO; Walls TJ; Nakano S; Camp S; Taylor P; Harper CM; Groover RV; Peterson HA; Jamieson DG; Engel AG
    Brain; 1993 Jun; 116 ( Pt 3)():633-53. PubMed ID: 8390325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.
    Liewluck T; Selcen D; Engel AG
    Muscle Nerve; 2011 Nov; 44(5):789-94. PubMed ID: 21952943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
    Stum M; Girard E; Bangratz M; Bernard V; Herbin M; Vignaud A; Ferry A; Davoine CS; Echaniz-Laguna A; René F; Marcel C; Molgó J; Fontaine B; Krejci E; Nicole S
    Hum Mol Genet; 2008 Oct; 17(20):3166-79. PubMed ID: 18647752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction at the motor end-plate and axon membrane in Guillain-Barré syndrome: a single-fiber EMG study.
    Spaans F; Vredeveld JW; Morré HH; Jacobs BC; De Baets MH
    Muscle Nerve; 2003 Apr; 27(4):426-34. PubMed ID: 12661043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol.
    Chan SH; Wong VC; Engel AG
    Pediatr Neurol; 2012 Aug; 47(2):137-40. PubMed ID: 22759693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.
    Garcia CC; Potian JG; Hognason K; Thyagarajan B; Sultatos LG; Souayah N; Routh VH; McArdle JJ
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(4):E551-61. PubMed ID: 22739110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological study of neuromuscular junction in congenital myasthenic syndromes, congenital myopathies, and chronic progressive external ophthalmoplegia.
    Caldas VM; Heise CO; Kouyoumdjian JA; Zambon AA; Silva AMS; Estephan EP; Zanoteli E
    Neuromuscul Disord; 2020 Nov; 30(11):897-903. PubMed ID: 33121830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.